ADMA: Adma Biologics Inc Company Profile & Statistics

About

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey.

Info & Links

CEO

Adam S. Grossman

Headquarters

465 STATE ROUTE 17
RAMSEY, NJ 07446, UNITED STATES

Auditor

CohnReznick LLP

Share holders

Employees

624

Adma Biologics Inc Statistics

Valuation Measures

Market Capitalization²

4.19B

Enterprise Value

4.21B

Enterprise Value/EBITDA(ttm)

33.85

Price to Earnings Ratio(ttm)

46.47

Price to Sales(ttm)

11.48

Price to Book(mrq)

18.95

Price to Cash(ytd)

365.82

Profitability

Gross Margin(ttm)

48.30%

Operating Margin(ttm)

24.64%

Profit Margin(ttm)

14.44%

Return on Equity(ttm)

53.20%

Return on Invested Capital(ttm)

19.91%

Return on Assets(ttm)

26.07%

Income Statement

Revenue(ttm)

382.81M

Revenue Per Share(ttm)

1.62

Gross Profit(ttm)

187.31M

EBITDA(ttm)³

124.39M

Net Income Available to Common(ttm)

68.13M

Diluted EPS(ttm)

0.28

Share Statistics

Beta (5Y Monthly)

0.70

52-Week Change

356.44%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

236.39M

Dividend Yield

0.00%

Float⁴

227.64M

% Held by Insiders

3.70%

% Held by Institutions

75.68%

Balance Sheet

Total Cash(mrq)

86.71M

Total Cash Per Share(mrq)

0.37

Total Debt(mrq)

111.38M

Total Debt/Equity(mrq)

48.03%

Current Ratio(mrq)

7.09%

Quick Ratio(mrq)

3.26%

Book Value Per Share(mrq)

0.98

Cash Flow

Operating Cash Flow Per Share(ytd)

0.28

Free Cash Flow(ytd)

62.99M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ADMA

Adma Biologics Inc

Adma Biologics Inc Profile